Skip to main content
. 2022 Mar 16;13(4):8076–8086. doi: 10.1080/21655979.2022.2052672

Figure 4.

Figure 4.

Upregulation of E2F1 was observed in breast cancer. (a) RPL5 expression data were acquired from StarBase database. (b) E2F1 mRNA expression levels were determined in paired tumor tissues and para-carcinoma tissues (n = 30) by qPCR. (c) E2F1 expression was detected in normal and tumor tissues using IHC assay. (d) The correlation between E2F1 and RPL5. (e) E2F1 mRNA expression levels were determined using qPCR in MCF-10A, MCF-7, BT-549, and MDA-MB-231 cells. (f) The mRNA expression levels of E2F1 after overexpressing RPL5 were estimated by qPCR. (g) The protein levels of E2F1 were measured by western blotting. **P < 0.01. ***P < 0.001.